Early Outcomes of Pharmacomechanical Thrombectomy in Acute Deep Vein Thrombosis Patients

Authors

  • Mehmet Ezelsoy Cardiovascular Surgery Department, Antakya State Hospital, Antakya
  • Gorkem Turunc Internal Medicine Department, Istanbul University, Istanbul
  • Muhammed Bayram Cardiovascular Surgery Department, Istanbul Mehmet Akif Ersoy Hospital, Istanbul

DOI:

https://doi.org/10.1532/hsf.1307

Abstract

Background: Acute lower extremity deep vein thrombosis (DVT) occurs due to obstruction of large veins by thrombus and its clinical findings are pain and swelling. If not treated, it can cause morbidity and mortality. Oral warfarin or low molecular weight heparin are applied in traditional treatment. However, recently, endovascular procedures have gained increasing popularity in deep vein thrombosis. In this study we aimed to compare our early results of pharmacomechanical thrombectomy (PMT) versus oral anticoagulation for acute deep vein thrombosis.
Methods: We comprised 50 patients presented with acute DVT between January 2013 and June 2014, who received either adjusted subcutaneous low molecular weight heparin (LMWH) or PMT followed by intravenous unfractionated heparin (UFH) for 5 days. Warfarin was administered to PMT patients for 3 months and at least 6 months for the control group.
Results: Median follow-up was 14 months (6-18 months). Recanalization within 6 months was found in 84.0%, femoral venous insufficiency was found in 36.0%, and postthrombotic syndrome (PTS) was found in 28.0% of the patients who received PMT treatment. The mean duration of symptoms was 11.0 days (range, 3-20 days). The mean duration of the procedure was 78.1 minutes (range, 55-100 min).
Conclusion: In contrast to medical therapy in the treatment of deep vein thrombosis, usage of catheter-directed thrombolysis experienced early recanalization with higher thrombus resolution. PMT with adjunctive thrombolytic therapy is an effective treatment modality in patients with significant DVT. Also, early thrombus removal in patients with acute DVT prevents development of postthrombotic morbidity. We believe that the efficacy and usage will increase with the experience of surgeons in the future.

Author Biographies

Mehmet Ezelsoy, Cardiovascular Surgery Department, Antakya State Hospital, Antakya

Cardiovascular Surgery Department

Gorkem Turunc, Internal Medicine Department, Istanbul University, Istanbul

Internal Medicine Department

References

Bush RL, Lin PH, Bates JT, Mureebe L, Zhou W, Lumsden AB. 2004. Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study. J Vasc Surg 40:965-70.

Decousus H, Leizorovicz A, Parent F, et al. 1998. A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep vein thrombosis. N Engl J Med 338:409-15.

Delis KT, Bountouroglou D, Mansfield AO. 2004. Venous claudication in iliofemoral thrombosis: longterm effects on venous hemodynamics, clinical status, and quality of life. Ann Surg 239:118-26.

Enden T, Kløw NE, Sandvik L, et al. 2009. Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost 7:1268e75.

Ginsberg JS, Hirsh J, Julian J, et al. 2001. Prevention and treatment of postphlebitic syndrome: results of a 3-part study. Arch Intern Med 16:2105-9.

Heit JA. 2008. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 28:370-2.

Imberti D, Ageno W, Dentali F, Donadini M, Manfredini R, Gallerani M. 2012. Retrievable vena cava filters: a clinical review. J Thromb Thrombolysis 33:258-66.

Kahn SR, Shrier I, Julian JA, et al. 2008. Determinants and time course of the postthrombotic syndrome. Ann Intern Med 149:698-707.

Karthikesalingam A, Young EL, Hinchliffe RJ, Loftus IM, Thompson MM, Holt PJE. 2011. A systematic review of percutaneous mechanical thrombectomy in the treatment of deep venous thrombosis. Eur J Vasc Endovasc Surg 41:554e565.

Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. 2008. Antithrombotic therapy for venous thromboembolic disease. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Ed). Chest 133:454S-545S.

Manninen H, Juutilainen A, Kaukanen E, Lehto S. 2012. Catheter-directed thrombolysis of proximal lower extremity deep vein thrombosis: a prospective trial with venographic and clinical follow-up. Eur J Radiol 81:1197-202.

Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. 1999. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 211:39-49.

Thomas ML, McAllister V. 1971. The radiological progression of deep venous thrombosis. Radiology 99:37e40.

U.S. Department of Health and Human Services. The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Sep 15. 2008.

Vedantham S, Vesely TM, Parti N, Darcy M, Hovsepian DM, Picus D. 2002. Lower extremity venous thrombolysis with adjunctive mechanical thrombectomy. J Vasc Interv Radiol 13:1001-8.

Published

2015-11-05

How to Cite

Ezelsoy, M., Turunc, G., & Bayram, M. (2015). Early Outcomes of Pharmacomechanical Thrombectomy in Acute Deep Vein Thrombosis Patients. The Heart Surgery Forum, 18(6), E222-E225. https://doi.org/10.1532/hsf.1307

Issue

Section

Articles

Most read articles by the same author(s)